Jill Harrison, PhD is the Executive Director of the National Institute on Aging (NIA) IMPACT Collaboratory and Assistant Professor of Practice in the Department of Health Services, Policy and Practice at Brown University School of Public Health. Prior to joining the NIA IMPACT Collaboratory, Dr. Harrison was the Director of Research for an international non-profit advocacy organization, founded by a patient, focused on implementing person-centered care initiatives in healthcare organizations in 27 countries. In addition to her role at the IMPACT Collaboratory, Dr. Harrison is a member of the Advisory Panel for Patient Engagement at the Patient-Centered Outcomes Research Institute (PCORI). She was recently the principal investigator of a PCORI Engagement Award about how patient-family advisory councils engage in research. Her research interests include: pragmatic trials in real-world settings, engaging residents of long-term care communities as evaluators of care quality, developing culturally congruent person-centered care approaches in healthcare systems, stakeholder engagement and organizational cultural change. She completed her post-doctorate at Brown University in health services research.
Two massive global public health problems exist simultaneously, Alzheimer’s disease and COVID-19, both with no effective medical treatments. AcademyHealth members Jill Harrison and Rosa Baier reflect on the urgent need to generate high-quality evidence about non-drug interventions to inform clinical and policy decision making about dementia care that works in this new context.
Embedded Pragmatic Trials for Alzheimer’s Disease: Difficult to Define and Implement, but Desperately Needed